The plasma-derivatives business of SK chemicals has earned a remarkable reputation recently and has achieved strong growth in the export market as well. SK Plasma was established in order to focus on the core competence of plasma-derivatives and to provide customers with higher quality products and services.
Curocell is a biotechnology company focused on medical and pharmaceutical research and development. The company's primary innovation is its OVIS™ technology, which enhances immune cells to counteract immune suppression in tumor microenvironments. Curocell is also developing CAR-T treatments that genetically modify human immune cells to improve their ability to recognize and eliminate cancer cells. Through these advancements, Curocell aims to provide effective therapeutic options for cancer treatment by harnessing and enhancing the body's natural immune responses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.